{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:46:08Z","timestamp":1792691168933,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T00:00:00Z","timestamp":1451347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/nrneurol.2015.234","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T05:32:18Z","timestamp":1451367138000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":240,"title":["Hepatitis E virus and neurological injury"],"prefix":"10.1038","volume":"12","author":[{"given":"Harry R.","family":"Dalton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J. J.","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan N.","family":"Mclean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Bendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,29]]},"reference":[{"key":"BFnrneurol2015234_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","volume":"379","author":"N Kamar","year":"2012","unstructured":"Kamar, N. et al. Hepatitis E. Lancet 379, 2477\u20132488 (2012).","journal-title":"Lancet"},{"key":"BFnrneurol2015234_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","volume":"8","author":"HR Dalton","year":"2008","unstructured":"Dalton, H. R., Bendall, R., Ijaz, S. & Banks, M. Hepatitis E: an emerging infection in developed countries. Lancet Infect. Dis. 8, 698\u2013709 (2008).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrneurol2015234_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/CMR.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar, N., Dalton, H. R., Abravanel, F. & Izopet, J. Hepatitis E virus infection. Clin. Microbiol. Rev. 27, 116\u2013138 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFnrneurol2015234_CR4","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/apt.12986","volume":"40","author":"KL Woolson","year":"2014","unstructured":"Woolson, K. L. et al. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment. Pharmacol. Ther. 40, 1282\u20131291 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrneurol2015234_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/MEG.0b013e3282f5195a","volume":"20","author":"HR Dalton","year":"2008","unstructured":"Dalton, H. R. et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur. J. Gastroenterol. Hepatol. 20, 784\u2013790 (2008).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrneurol2015234_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1365-2893.2006.00800.x","volume":"14","author":"HR Dalton","year":"2007","unstructured":"Dalton, H. R. et al. Autochthonous hepatitis E in southwest England. J. Viral Hepat. 14, 304\u2013309 (2007).","journal-title":"J. Viral Hepat."},{"key":"BFnrneurol2015234_CR7","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1086\/444396","volume":"192","author":"S Ijaz","year":"2005","unstructured":"Ijaz, S. et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J. Infect. Dis. 192, 1166\u20131172 (2005).","journal-title":"J. Infect. Dis."},{"key":"BFnrneurol2015234_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jmv.20206","volume":"74","author":"JM Mansuy","year":"2004","unstructured":"Mansuy, J. M. et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J. Med. Virol. 74, 419\u2013424 (2004).","journal-title":"J. Med. Virol."},{"key":"BFnrneurol2015234_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1086\/313730","volume":"30","author":"TH Tsang","year":"2000","unstructured":"Tsang, T. H. et al. Acute hepatitis E infection acquired in California. Clin. Infect. Dis. 30, 618\u2013619 (2000).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrneurol2015234_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0168-8278(00)80316-5","volume":"33","author":"S Pina","year":"2000","unstructured":"Pina, S., Buti, M., Cotrina, M., Piella, J. & Girones, R. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J. Hepatol. 33, 826\u2013833 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrneurol2015234_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00535-003-1359-5","volume":"39","author":"S Sainokami","year":"2004","unstructured":"Sainokami, S. et al. Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A. J. Gastroenterol. 39, 640\u2013648 (2004).","journal-title":"J. Gastroenterol."},{"key":"BFnrneurol2015234_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1086\/345439","volume":"36","author":"MA Widdowson","year":"2003","unstructured":"Widdowson, M. A. et al. Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in the Netherlands. Clin. Infect. Dis. 36, 29\u201333 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrneurol2015234_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"Kamar, N. et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 358, 811\u2013817 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015234_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMc0708687","volume":"358","author":"R Gerolami","year":"2008","unstructured":"Gerolami, R., Moal, V. & Colson, P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N. Engl. J. Med. 358, 859\u2013860 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015234_CR15","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","volume":"140","author":"N Kamar","year":"2011","unstructured":"Kamar, N. et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 140, 1481\u20131489 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrneurol2015234_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJMc0903778","volume":"361","author":"HR Dalton","year":"2009","unstructured":"Dalton, H. R., Bendall, R., Keane, F., Tedder, R. & Ijaz, S. Persistent carriage of hepatitis E virus in patients with HIV infection. N. Engl. J. Med. 361, 1025\u20131027 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015234_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/hep.27611","volume":"62","author":"HL Zaaijer","year":"2014","unstructured":"Zaaijer, H. L. No artifact, hepatitis E is emerging. Hepatology 62, 654 (2014).","journal-title":"Hepatology"},{"key":"BFnrneurol2015234_CR18","doi-asserted-by":"publisher","first-page":"20550","DOI":"10.2807\/1560-7917.ES2013.18.31.20550","volume":"18","author":"E Slot","year":"2013","unstructured":"Slot, E. et al. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill. 18, 20550 (2013).","journal-title":"Euro Surveill."},{"key":"BFnrneurol2015234_CR19","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3201\/eid2011.140516","volume":"20","author":"P Gallian","year":"2014","unstructured":"Gallian, P. et al. Hepatitis E virus infections in blood donors, France. Emerg. Infect. Dis. 20, 1914\u20131917 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR20","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3201\/eid1712.110371","volume":"17","author":"JM Mansuy","year":"2011","unstructured":"Mansuy, J. M. et al. Hepatitis E virus antibody in blood donors, France. Emerg. Infect. Dis. 17, 2309\u20132312 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR21","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1128\/JCM.01119-12","volume":"50","author":"T Vollmer","year":"2012","unstructured":"Vollmer, T. et al. Novel approach for detection of hepatitis E virus infection in German blood donors. J. Clin. Microbiol. 50, 2708\u20132713 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrneurol2015234_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1423-0410.2011.01583.x","volume":"103","author":"SA Baylis","year":"2012","unstructured":"Baylis, S. A., Gartner, T., Nick, S., Ovemyr, J. & Blumel, J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 103, 89\u201390 (2012).","journal-title":"Vox Sang."},{"key":"BFnrneurol2015234_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/infdis\/jis688","volume":"207","author":"JJ Wenzel","year":"2013","unstructured":"Wenzel, J. J., Preiss, J., Schemmerer, M., Huber, B. & Jilg, W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J. Infect. Dis. 207, 497\u2013500 (2013).","journal-title":"J. Infect. Dis."},{"key":"BFnrneurol2015234_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jmv.20125","volume":"73","author":"S Fukuda","year":"2004","unstructured":"Fukuda, S. et al. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J. Med. Virol. 73, 554\u2013561 (2004).","journal-title":"J. Med. Virol."},{"key":"BFnrneurol2015234_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1128\/JCM.01466-09","volume":"48","author":"QS Guo","year":"2010","unstructured":"Guo, Q. S. et al. Prevalence of hepatitis E virus in Chinese blood donors. J. Clin. Microbiol. 48, 317\u2013318 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrneurol2015234_CR26","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","volume":"384","author":"PE Hewitt","year":"2014","unstructured":"Hewitt, P. E. et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 384, 1766\u20131773 (2014).","journal-title":"Lancet"},{"key":"BFnrneurol2015234_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1423-0410.2011.01554.x","volume":"102","author":"S Ijaz","year":"2012","unstructured":"Ijaz, S., Szypulska, R., Tettmar, K. I., Kitchen, A. & Tedder, R. S. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang. 102, 272 (2012).","journal-title":"Vox Sang."},{"key":"BFnrneurol2015234_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1423-0410.2010.01412.x","volume":"100","author":"MA Beale","year":"2011","unstructured":"Beale, M. A., Tettmar, K., Szypulska, R., Tedder, R. S. & Ijaz, S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang. 100, 340\u2013342 (2011).","journal-title":"Vox Sang."},{"key":"BFnrneurol2015234_CR29","doi-asserted-by":"publisher","first-page":"e0119576","DOI":"10.1371\/journal.pone.0119576","volume":"10","author":"C Fischer","year":"2015","unstructured":"Fischer, C. et al. Seroprevalence and incidence of hepatitis E in blood donors in Upper Austria. PLoS ONE 10, e0119576 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2015234_CR30","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1111\/trf.12326","volume":"53","author":"C Xu","year":"2013","unstructured":"Xu, C. et al. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion 53, 2505\u20132511 (2013).","journal-title":"Transfusion"},{"key":"BFnrneurol2015234_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/vox.12056","volume":"105","author":"A Cleland","year":"2013","unstructured":"Cleland, A. et al. Hepatitis E virus in Scottish blood donors. Vox Sang. 105, 283\u2013289 (2013).","journal-title":"Vox Sang."},{"key":"BFnrneurol2015234_CR32","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.3201\/eid2011.140412","volume":"20","author":"AC Shrestha","year":"2014","unstructured":"Shrestha, A. C. et al. Hepatitis E virus and implications for blood supply safety, Australia. Emerg. Infect. Dis. 20, 1940\u20131942 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR33","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1440-1746.2007.04894.x","volume":"22","author":"HR Dalton","year":"2007","unstructured":"Dalton, H. R. et al. Hepatitis E in New Zealand. J. Gastroenterol. Hepatol. 22, 1236\u20131240 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrneurol2015234_CR34","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3201\/eid2006.130562","volume":"20","author":"JS Halliday","year":"2014","unstructured":"Halliday, J. S. et al. Hepatitis E virus infection, Papua New Guinea, Fiji, and Kiribati, 2003\u20132005. Emerg. Infect. Dis. 20, 1057\u20131058 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR35","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1017\/S0950268810002177","volume":"139","author":"MF Faramawi","year":"2011","unstructured":"Faramawi, M. F., Johnson, E., Chen, S. & Pannala, P. R. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol. Infect. 139, 1145\u20131150 (2011).","journal-title":"Epidemiol. Infect."},{"key":"BFnrneurol2015234_CR36","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1086\/655899","volume":"202","author":"F Legrand-Abravanel","year":"2010","unstructured":"Legrand-Abravanel, F. et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J. Infect. Dis. 202, 835\u2013844 (2010).","journal-title":"J. Infect. Dis."},{"key":"BFnrneurol2015234_CR37","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/S0002-9270(00)02202-4","volume":"95","author":"A Sood","year":"2000","unstructured":"Sood, A., Midha, V. & Sood, N. Guillain\u2013Barr\u00e9 syndrome with acute hepatitis E. Am. J. Gastroenterol. 95, 3667\u20133668 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrneurol2015234_CR38","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1212\/WNL.57.10.1935","volume":"57","author":"D Kejariwal","year":"2001","unstructured":"Kejariwal, D., Roy, S. & Sarkar, N. Seizure associated with acute hepatitis E. Neurology 57, 1935 (2001).","journal-title":"Neurology"},{"key":"BFnrneurol2015234_CR39","first-page":"216","volume":"24","author":"P Kamani","year":"2005","unstructured":"Kamani, P. et al. Guillain\u2013Barr\u00e9 syndrome associated with acute hepatitis E. Indian J. Gastroenterol. 24, 216 (2005).","journal-title":"Indian J. Gastroenterol."},{"key":"BFnrneurol2015234_CR40","first-page":"418","volume":"54","author":"VK Dixit","year":"2006","unstructured":"Dixit, V. K., Abhilash, V. B., Kate, M. P. & Jain, A. K. Hepatitis E infection with Bell's palsy. J. Assoc. Physicians India 54, 418 (2006).","journal-title":"J. Assoc. Physicians India"},{"key":"BFnrneurol2015234_CR41","first-page":"365","volume":"43","author":"K Mandal","year":"2006","unstructured":"Mandal, K. & Chopra, N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr. 43, 365\u2013366 (2006).","journal-title":"Indian Pediatr."},{"key":"BFnrneurol2015234_CR42","first-page":"102","volume":"26","author":"GG Joshi","year":"2007","unstructured":"Joshi, G. G. et al. Acute viral hepatitis E and Japanese encephalitis: an unusual co-occurrence. Indian J. Gastroenterol. 26, 102\u2013103 (2007).","journal-title":"Indian J. Gastroenterol."},{"key":"BFnrneurol2015234_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clineuro.2008.09.005","volume":"111","author":"F Fong","year":"2009","unstructured":"Fong, F. & Illahi, M. Neuralgic amyotrophy associated with hepatitis E virus. Clin. Neurol. Neurosurg. 111, 193\u2013195 (2009).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"BFnrneurol2015234_CR44","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3748\/wjg.15.1645","volume":"15","author":"JP Loly","year":"2009","unstructured":"Loly, J. P. et al. Guillain\u2013Barr\u00e9 syndrome following hepatitis E. World J. Gastroenterol. 15, 1645\u20131647 (2009).","journal-title":"World J. Gastroenterol."},{"key":"BFnrneurol2015234_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/00365540903496551","volume":"42","author":"P Rianthavorn","year":"2010","unstructured":"Rianthavorn, P. et al. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand. J. Infect. Dis. 42, 395\u2013400 (2010).","journal-title":"Scand. J. Infect. Dis."},{"key":"BFnrneurol2015234_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3201\/eid1702.100856","volume":"17","author":"N Kamar","year":"2011","unstructured":"Kamar, N. et al. Hepatitis E virus and neurologic disorders. Emerg. Infect. Dis. 17, 173\u2013179 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR47","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/j.1600-6143.2010.03068.x","volume":"10","author":"N Kamar","year":"2010","unstructured":"Kamar, N. et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am. J. Transplant. 10, 1321\u20131324 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneurol2015234_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.7326\/0003-4819-155-7-201110040-00017","volume":"155","author":"H Dalton","year":"2011","unstructured":"Dalton, H., Keane, F., Bendall, R., Mathew, J. & Ijaz, S. Treatment of chronic hepatitis E in a HIV positive patient. Ann. Intern. Med. 155, 479\u2013480 (2011).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneurol2015234_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11845-010-0635-7","volume":"180","author":"S Cronin","year":"2011","unstructured":"Cronin, S., McNicholas, R., Kavanagh, E., Reid, V. & O'Rourke, K. Anti-glycolipid GM2-positive Guillain\u2013Barr\u00e9 syndrome due to hepatitis E infection. Ir. J. Med. Sci. 180, 255\u2013257 (2011).","journal-title":"Ir. J. Med. Sci."},{"key":"BFnrneurol2015234_CR50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s15010-011-0185-6","volume":"40","author":"I Maurissen","year":"2012","unstructured":"Maurissen, I., Jeurissen, A., Strauven, T., Sprengers, D. & De Schepper, B. First case of anti-ganglioside GM1-positive Guillain\u2013Barr\u00e9 syndrome due to hepatitis E virus infection. Infection 40, 323\u2013326 (2012).","journal-title":"Infection"},{"key":"BFnrneurol2015234_CR51","first-page":"1510","volume":"17","author":"LA Despierres","year":"2011","unstructured":"Despierres, L. A. et al. Neurologic disorders and hepatitis E, France, 2010. Emerg. Infect. Dis. 17, 1510\u20131512 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR52","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jhep.2012.05.010","volume":"57","author":"A Del Bello","year":"2012","unstructured":"Del Bello, A., Arne-Bes, M. C., Lavayssiere, L. & Kamar, N. Hepatitis E virus-induced severe myositis. J. Hepatol. 57, 1152\u20131153 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrneurol2015234_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jocn.2011.06.024","volume":"19","author":"AC Tse","year":"2012","unstructured":"Tse, A. C., Cheung, R. T., Ho, S. L. & Chan, K. H. Guillain\u2013Barr\u00e9 syndrome associated with acute hepatitis E infection. J. Clin. Neurosci. 19, 607\u2013608 (2012).","journal-title":"J. Clin. Neurosci."},{"key":"BFnrneurol2015234_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neurol.2011.07.014","volume":"168","author":"ML Inghilleri","year":"2012","unstructured":"Inghilleri, M. L., Grini Mazouzi, M. & Juntas Morales, R. Neuralgic amyotrophy as a manifestation of hepatitis E infection. Rev. Neurol. (Paris) 168, 383\u2013384 (in French) (2012).","journal-title":"Rev. Neurol. (Paris)"},{"key":"BFnrneurol2015234_CR55","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s13365-013-0156-z","volume":"19","author":"B Sharma","year":"2013","unstructured":"Sharma, B., Nagpal, K., Bakki Sannegowda, R. & Prakash, S. Hepatitis E with Gullain\u2013Barr\u00e9 syndrome: still a rare association. J. Neurovirol. 19, 186\u2013187 (2013).","journal-title":"J. Neurovirol."},{"key":"BFnrneurol2015234_CR56","doi-asserted-by":"publisher","first-page":"20563","DOI":"10.2807\/1560-7917.ES2013.18.34.20563","volume":"18","author":"L Santos","year":"2013","unstructured":"Santos, L. et al. Acute hepatitis E complicated by Guillain\u2013Barr\u00e9 syndrome in Portugal, December 2012 \u2014 a case report. Euro Surveill. 18, 20563 (2013).","journal-title":"Euro Surveill."},{"key":"BFnrneurol2015234_CR57","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.clinre.2013.08.011","volume":"38","author":"A Motte","year":"2014","unstructured":"Motte, A., Franques, J., Weitten, T. & Colson, P. Hepatitis E-associated Parsonage\u2013Turner syndrome, France. Clin. Res. Hepatol. Gastroenterol. 38, e11\u2013e14 (2014).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"BFnrneurol2015234_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.12688\/f1000research.2-259.v1","volume":"2","author":"X Moisset","year":"2013","unstructured":"Moisset, X. et al. Severe bilateral amyotrophic neuralgia associated with major dysphagia secondary to acute hepatitis E. F1000Res. 2, 259 (2013).","journal-title":"F1000Res."},{"key":"BFnrneurol2015234_CR59","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s10620-013-2628-7","volume":"58","author":"VC Maddukuri","year":"2013","unstructured":"Maddukuri, V. C. et al. Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient. Dig. Dis. Sci. 58, 2413\u20132416 (2013).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrneurol2015234_CR60","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/cit512","volume":"57","author":"CH Geurtsvankessel","year":"2013","unstructured":"Geurtsvankessel, C. H. et al. Hepatitis E and Guillain\u2013Barr\u00e9 syndrome. Clin. Infect. Dis. 57, 1369\u20131370 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrneurol2015234_CR61","doi-asserted-by":"publisher","unstructured":"de Vries, M. A., Samijn, J. P., de Man, R. & Boots, J. M. Hepatitis E-associated encephalopathy in a renal transplant recipient. BMJ Case Rep. http:\/\/dx.doi.org\/10.1136\/bcr-2014-204244 (2014).","DOI":"10.1136\/bcr-2014-204244"},{"key":"BFnrneurol2015234_CR62","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.revmed.2013.05.005","volume":"35","author":"T Comont","year":"2014","unstructured":"Comont, T. et al. Acute hepatitis E infection associated with Guillain\u2013Barr\u00e9 syndrome in an immunocompetent patient. Rev. Med. Interne 35, 333\u2013336 (in French) (2014).","journal-title":"Rev. Med. Interne"},{"key":"BFnrneurol2015234_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s15010-013-0448-5","volume":"42","author":"N Scharn","year":"2014","unstructured":"Scharn, N. et al. Guillain\u2013Barr\u00e9 syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c. Infection 42, 171\u2013173 (2014).","journal-title":"Infection"},{"key":"BFnrneurol2015234_CR64","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jcv.2014.01.026","volume":"60","author":"A Deroux","year":"2014","unstructured":"Deroux, A. et al. Association between hepatitis E and neurological disorders: two case studies and literature review. J. Clin. Virol. 60, 60\u201362 (2014).","journal-title":"J. Clin. Virol."},{"key":"BFnrneurol2015234_CR65","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3201\/eid2005.131551","volume":"20","author":"A Belbezier","year":"2014","unstructured":"Belbezier, A., Deroux, A., Sarrot-Reynauld, F., Larrat, S. & Bouillet, L. Myasthenia gravis associated with acute hepatitis E infection in immunocompetent woman. Emerg. Infect. Dis. 20, 908\u2013910 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR66","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10072-014-1731-7","volume":"35","author":"XD Chen","year":"2014","unstructured":"Chen, X. D., Zhou, Y. T., Zhou, J. J., Wang, Y. W. & Tong, D. M. Guillain\u2013Barr\u00e9 syndrome and encephalitis\/encephalopathy of a rare case of Northern China acute severe hepatitis E infection. Neurol. Sci. 35, 1461\u20131463 (2014).","journal-title":"Neurol. Sci."},{"key":"BFnrneurol2015234_CR67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","volume":"82","author":"B van den Berg","year":"2014","unstructured":"van den Berg, B. et al. Guillain\u2013Barr\u00e9 syndrome associated with preceding hepatitis E virus infection. Neurology 82, 491\u2013497 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol2015234_CR68","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/WNL.0000000000000112","volume":"82","author":"JJ van Eijk","year":"2014","unstructured":"van Eijk, J. J. et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology 82, 498\u2013503 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol2015234_CR69","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1177\/0036933015572093","volume":"60","author":"S Bennett","year":"2015","unstructured":"Bennett, S., Gunson, R. N. & Li, K. Hepatitis E virus infection presenting with paraesthesia. Scott. Med. J. 60, e27\u2013e29 (2015).","journal-title":"Scott. Med. J."},{"key":"BFnrneurol2015234_CR70","first-page":"1928","volume":"21","author":"H Blasco Perrin","year":"2015","unstructured":"Blasco Perrin, H. et al. Neurologic disorders in non-immunocompromized patients with auotchtonous acute hepatitis E. Emerg. Infect. Dis. 21, 1928\u20131934 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR71","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jns.2015.03.003","volume":"351","author":"BF D\u00e9card","year":"2015","unstructured":"D\u00e9card, B. F. et al. Hepatitis-E virus associated neuralgic amyotrophy with sustained plexus brachialis swelling visualized by high-resolution ultrasound. J. Neurol. Sci. 351, 208\u2013210 (2015).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2015234_CR72","doi-asserted-by":"publisher","unstructured":"Theochari, E., Vincent-Smith, L. & Ellis, C. Neuralgic amyotrophy complicating acute hepatitis E infection: a rare association. BMJ Case Rep. http:\/\/dx.doi.org\/10.1136\/bcr-2014-207669 (2015).","DOI":"10.1136\/bcr-2014-207669"},{"key":"BFnrneurol2015234_CR73","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0973-6883(12)60082-6","volume":"2","author":"AK Jha","year":"2012","unstructured":"Jha, A. K., Nijhawan, S., Nepalia, S. & Suchismita, A. Association of Bell's palsy with hepatitis E virus infection: a rare entity. J. Clin. Exp. Hepatol. 2, 88\u201390 (2012).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"BFnrneurol2015234_CR74","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.revmed.2011.11.004","volume":"33","author":"P Carli","year":"2012","unstructured":"Carli, P. et al. Shoulder pain in a 30-year-old man. Rev. Med. Interne 33, 111\u2013114 (in French) (2012).","journal-title":"Rev. Med. Interne"},{"key":"BFnrneurol2015234_CR75","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/00365521.2011.643483","volume":"47","author":"MC Cheung","year":"2012","unstructured":"Cheung, M. C., Maguire, J., Carey, I., Wendon, J. & Agarwal, K. Hepatitis E \u2014 an unexpected problem at home. Scand. J. Gastroenterol. 47, 253 (2012).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrneurol2015234_CR76","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.dld.2013.05.006","volume":"45","author":"AM Peri","year":"2013","unstructured":"Peri, A. M., Milazzo, L., Meroni, L. & Antinori, S. Radiculoneuropathy associated with acute hepatitis E. Dig. Liver Dis. 45, 963\u2013964 (2013).","journal-title":"Dig. Liver Dis."},{"key":"BFnrneurol2015234_CR77","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.medcli.2015.01.021","volume":"145","author":"L Mart\u00ednez Rodr\u00edguez","year":"2015","unstructured":"Mart\u00ednez Rodr\u00edguez, L., Carvajal, P. & Mor\u00eds, G. Neuralgic amyotrophy associated to hepatitis E virus infection. Med. Clin. (Barc.) 145, 462\u2013463 (in Spanish) (2015).","journal-title":"Med. Clin. (Barc.)"},{"key":"BFnrneurol2015234_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jcv.2015.06.091","volume":"69","author":"A Dartevel","year":"2015","unstructured":"Dartevel, A. et al. Hepatitis E and neuralgic amyotrophy: five cases and review of literature. J. Clin. Virol. 69, 156\u2013164 (2015).","journal-title":"J. Clin. Virol."},{"key":"BFnrneurol2015234_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke, C. et al. Diagnosis of Guillain\u2013Barr\u00e9 syndrome and validation of Brighton criteria. Brain 137, 33\u201343 (2014).","journal-title":"Brain"},{"key":"BFnrneurol2015234_CR80","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","volume":"51","author":"BC Jacobs","year":"1998","unstructured":"Jacobs, B. C. et al. The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case\u2013control study. Neurology 51, 1110\u20131115 (1998).","journal-title":"Neurology"},{"key":"BFnrneurol2015234_CR81","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1212\/WNL.46.1.96","volume":"46","author":"PG Oomes","year":"1996","unstructured":"Oomes, P. G., van der Meche, F. G. & Kleyweg, R. P. Liver function disturbances in Guillain\u2013Barr\u00e9 syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain\u2013Barr\u00e9 Study Group. Neurology 46, 96\u2013100 (1996).","journal-title":"Neurology"},{"key":"BFnrneurol2015234_CR82","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrneurol.2011.62","volume":"7","author":"N van Alfen","year":"2011","unstructured":"van Alfen, N. Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat. Rev. Neurol. 7, 315\u2013322 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol2015234_CR83","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/brain\/awh722","volume":"129","author":"N van Alfen","year":"2006","unstructured":"van Alfen, N. & van Engelen, B. G. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 129, 438\u2013450 (2006).","journal-title":"Brain"},{"key":"BFnrneurol2015234_CR84","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1620\/tjem.236.263","volume":"236","author":"Y Yazaki","year":"2015","unstructured":"Yazaki, Y. et al. Characteristics of 20 patients with autochthonous acute hepatitis E in Hokkaido, Japan: first report of bilateral facial palsy following the infection with genotype 4 hepatitis E virus. Tohoku J. Exp. Med. 236, 263\u2013271 (2015).","journal-title":"Tohoku J. Exp. Med."},{"key":"BFnrneurol2015234_CR85","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3201\/eid1501.080296","volume":"15","author":"F Legrand-Abravanel","year":"2009","unstructured":"Legrand-Abravanel, F. et al. Hepatitis E virus genotype 3 diversity, France. Emerg. Infect. Dis. 15, 110\u2013114 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrneurol2015234_CR86","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/jnnp.74.9.1267","volume":"74","author":"R Nemni","year":"2003","unstructured":"Nemni, R. et al. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J. Neurol. Neurosurg. Psychiatry 74, 1267\u20131271 (2003).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2015234_CR87","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1212\/01.WNL.0000044399.71601.EA","volume":"60","author":"FJ Authier","year":"2003","unstructured":"Authier, F. J. et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 60, 808\u2013812 (2003).","journal-title":"Neurology"},{"key":"BFnrneurol2015234_CR88","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1097\/01.aids.0000192081.33938.2f","volume":"19","author":"P Cacoub","year":"2005","unstructured":"Cacoub, P., Saadoun, D., Limal, N., Leger, J. M. & Maisonobe, T. Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS 19, S128\u2013S134 (2005).","journal-title":"AIDS"},{"key":"BFnrneurol2015234_CR89","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1128\/JVI.00146-12","volume":"86","author":"P Shukla","year":"2012","unstructured":"Shukla, P. et al. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J. Virol. 86, 5697\u20135707 (2012).","journal-title":"J. Virol."},{"key":"BFnrneurol2015234_CR90","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.0402391101","volume":"101","author":"N Yuki","year":"2004","unstructured":"Yuki, N. et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain\u2013Barr\u00e9 syndrome. Proc. Natl Acad. Sci. USA 101, 11404\u201311409 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2015234_CR91","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1113\/jphysiol.2009.171702","volume":"587","author":"JJ Plomp","year":"2009","unstructured":"Plomp, J. J. & Willison, H. J. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J. Physiol. 587, 3979\u20133999 (2009).","journal-title":"J. Physiol."},{"key":"BFnrneurol2015234_CR92","doi-asserted-by":"publisher","first-page":"e0128361","DOI":"10.1371\/journal.pone.0128361","volume":"10","author":"N van Alfen","year":"2015","unstructured":"van Alfen, N. et al. Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care seting \u2014 a prospective cohort study. PLoS ONE 10, e0128361 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2015234_CR93","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/jmv.21656","volume":"82","author":"R Bendall","year":"2010","unstructured":"Bendall, R., Ellis, V., Ijaz, S., Ali, R. & Dalton, H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J. Med. Virol. 82, 799\u2013805 (2010).","journal-title":"J. Med. Virol."},{"key":"BFnrneurol2015234_CR94","doi-asserted-by":"crossref","unstructured":"French Cooperative Group on Plasma Exchange in Guillain\u2013Barr\u00e9 syndrome. Efficiency of plasma exchange in Guillain\u2013Barr\u00e9 syndrome: role of replacement fluids. Ann. Neurol. 22, 753\u2013761 (1987).","DOI":"10.1002\/ana.410220612"},{"key":"BFnrneurol2015234_CR95","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes, R. A. & Cornblath, D. R. Guillain\u2013Barr\u00e9 syndrome. Lancet 366, 1653\u20131666 (2005).","journal-title":"Lancet"},{"key":"BFnrneurol2015234_CR96","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1136\/jnnp.2008.163386","volume":"80","author":"JJ van Eijk","year":"2009","unstructured":"van Eijk, J. J. et al. Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study. J. Neurol. Neurosurg. Psychiatry 80, 1120\u20131124 (2009).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2015234_CR97","first-page":"CD006976","volume":"3","author":"N van Alfen","year":"2009","unstructured":"van Alfen, N., van Engelen, B. G. & Hughes, R. A. Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database Syst. Rev. 3, CD006976 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrneurol2015234_CR98","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jcv.2010.02.016","volume":"48","author":"E Fourquet","year":"2010","unstructured":"Fourquet, E. et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J. Clin. Virol. 48, 73\u201374 (2010).","journal-title":"J. Clin. Virol."},{"key":"BFnrneurol2015234_CR99","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1473-3099(14)70823-0","volume":"14","author":"S Pischke","year":"2014","unstructured":"Pischke, S., Behrendt, P., Manns, M. P. & Wedemeyer, H. HEV-associated cryoglobulinaemia and extrahepatic manifestations of hepatitis E. Lancet Infect. Dis. 14, 678\u2013679 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"BFnrneurol2015234_CR100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e318245f14c","volume":"93","author":"N Kamar","year":"2012","unstructured":"Kamar, N. et al. Hepatitis E virus and the kidney in solid-organ-transplant patients. Transplantation 93, 617\u2013623 (2012).","journal-title":"Transplantation"},{"key":"BFnrneurol2015234_CR101","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jcv.2011.04.009","volume":"51","author":"C Deniel","year":"2011","unstructured":"Deniel, C. et al. Acute pancreatitis: a rare complication of acute hepatitis E. J. Clin. Virol. 51, 202\u2013204 (2011).","journal-title":"J. Clin. Virol."},{"key":"BFnrneurol2015234_CR102","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s10067-007-0595-0","volume":"26","author":"J Serratrice","year":"2007","unstructured":"Serratrice, J. et al. Acute polyarthritis revealing hepatitis E. Clin. Rheumatol. 26, 1973\u20131975 (2007).","journal-title":"Clin. Rheumatol."},{"key":"BFnrneurol2015234_CR103","doi-asserted-by":"publisher","unstructured":"Dumoulin, F. L. & Liese, H. Acute hepatitis E virus infection and autoimmune thyroiditis: yet another trigger? BMJ Case Rep. http:\/\/dx.doi.org\/10.1136\/bcr.12.2011.5441 (2012).","DOI":"10.1136\/bcr.12.2011.5441"},{"key":"BFnrneurol2015234_CR104","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1056\/NEJMra1204512","volume":"367","author":"JH Hoofnagle","year":"2012","unstructured":"Hoofnagle, J. H., Nelson, K. & Purcell, R. H. Hepatitis E. N. Engl. J. Med. 367, 1237\u20131244 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2015234_CR105","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/hep.25505","volume":"55","author":"DB Rein","year":"2012","unstructured":"Rein, D. B., Stevens, G. A., Theaker, J., Wittenborn, J. S. & Wiersma, S. T. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 55, 988\u2013997 (2012).","journal-title":"Hepatology"},{"key":"BFnrneurol2015234_CR106","doi-asserted-by":"publisher","unstructured":"Stramer, S. L. et al. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion http:\/\/dx.doi.org\/10.1111\/trf.13355 (2015).","DOI":"10.1111\/trf.13355"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.234","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2015.234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:16:50Z","timestamp":1684455410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2015.234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,29]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFnrneurol2015234"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2015.234","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,29]]},"assertion":[{"value":"29 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.R.D. has received travel and accommodation costs and consultancy fees from GlaxoSmithKline, Wantai and Roche; travel, accommodation and lecture fees from Merck, Gilead and GFE Blut; and travel and accommodation fees from the Falk Foundation. N.K. has received travel and accommodation costs and consultancy fees from Novartis and Merck; travel, accommodation and lecture fees from Gilead, Novartis, Astellas, BMS, Amgen and Fresenius. J.J.J.v.E. has received travel and accommodation costs or consultancy or lecture fees from Merck, Biogen Idec, Novartis and Teva Pharmaceutical Industries. B.C.J. has received research support from Prinses Beatrix Spierfonds, CSL-Behring and Grifols, and travel support from Baxter Biopharmaceutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}